Veracyte, Inc. (VCYT): Net Income
$66.35M
Year ended 2025-12-31
$114.48M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $66.35M | +174.9% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $24.14M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$74.40M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$36.56M | n/m | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | -$75.56M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$34.91M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$12.60M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$23.00M | n/a | 2021-02-22, From 2018-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Veracyte, Inc. (VCYT) | 2025-12-31 | $66.35M | +174.9% |
| CareDx, Inc. (CDNA) | 2025-12-31 | -$21.35M | n/m |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | -$24.16M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | -$68.09M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$60.51M | n/m |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $7.45M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$416.28M | n/m |
| GRAIL, Inc. (GRAL) | 2025-12-31 | -$408.35M | n/m |
| RadNet, Inc. (RDNT) | 2025-12-31 | -$18.65M | n/m |
Compare VCYT, CDNA, CSTL, CAI side by side · Screen every company in Services-Medical Laboratories ↗